Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 3
1975 2
1979 1
1980 1
1981 6
1982 3
1983 4
1984 3
1985 6
1986 6
1987 5
1988 4
1989 1
1991 3
1992 3
1995 1
1997 1
1999 1
2001 4
2004 1
2005 2
2009 3
2010 2
2011 2
2012 5
2013 1
2014 2
2015 1
2016 1
2017 3
2018 2
2019 2
2020 2
2021 2
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
Dampier CD, Telen MJ, Wun T, Brown RC, Desai P, El Rassi F, Fuh B, Kanter J, Pastore Y, Rothman J, Taylor JG, Readett D, Sivamurthy KM, Tammara B, Tseng LJ, Lozier JN, Thackray H, Magnani JL, Hassell KL; RESET Investigators. Dampier CD, et al. Among authors: magnani jl. Blood. 2023 Jan 12;141(2):168-179. doi: 10.1182/blood.2022015797. Blood. 2023. PMID: 35981565 Free article. Clinical Trial.
From carbohydrate leads to glycomimetic drugs.
Ernst B, Magnani JL. Ernst B, et al. Among authors: magnani jl. Nat Rev Drug Discov. 2009 Aug;8(8):661-77. doi: 10.1038/nrd2852. Epub 2009 Jul 24. Nat Rev Drug Discov. 2009. PMID: 19629075 Free PMC article. Review.
FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML.
Jia Y, Zhang W, Basyal M, Chang KH, Ostermann L, Burks JK, Ly C, Mu-Mosley H, Zhang Q, Han X, Fogler WE, Magnani JL, Lesegretain A, Zal AA, Zal T, Andreeff M. Jia Y, et al. Among authors: magnani jl. Leukemia. 2023 Jun;37(6):1379-1383. doi: 10.1038/s41375-023-01897-x. Epub 2023 Apr 21. Leukemia. 2023. PMID: 37085610 Free PMC article. No abstract available.
E-selectin inhibitor is superior to low-molecular-weight heparin for the treatment of experimental venous thrombosis.
Myers DD Jr, Ning J, Lester P, Adili R, Hawley A, Durham L, Dunivant V, Reynolds G, Crego K, Sood S, Sigler R, Fogler WE, Magnani JL, Holinstat M, Wakefield T. Myers DD Jr, et al. Among authors: magnani jl. J Vasc Surg Venous Lymphat Disord. 2022 Jan;10(1):211-220. doi: 10.1016/j.jvsv.2020.12.086. Epub 2021 Apr 17. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 33872819
90 results